Sort
82,697 grants matching “vaccine development”
Computational Biology and Biostatistics Core
$1,414,675Bette T. Korb · Duke University · U19 · FY2008 · AI
Host-parasite-vector interactions during malaria transmission
$1,414,629Joel Vega-Rodriguez · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
SVEU - Operation of a NHP Breeding Colony
$1,414,508Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2020 · AI
Host-parasite-vector interactions during malaria transmission
$1,414,474Joel Vega-Rodriguez · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
CoVPN 3001 A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine SDMC
$1,414,274Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · AI
Research Capacity Core
$1,414,032Ming Bo Huang · Morehouse School Of Medicine · U54 · FY2025 · MD
Therapeutic Vaccination for HIV Using VEE Vectors
$1,413,970University Of North Carolina Chapel Hill · P01 · FY2004 · AI
T Cell Immune Responses To HIV And Other Pathogens
$1,413,801Richard A Koup · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Testing of Blood Samples for Immune Response and Vaccine Research
$1,413,801Richard A Koup · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Simian Vaccine Evaluation Unit (SVEU)
$1,413,590Michael Agy · University Of Washington · N01 · FY2013 · AI
T CELL MEMORY GENERATION AND FUNCTION
$1,413,550Trudeau Institute, Inc. · P01 · FY2002 · AI
SARS-CoV-2 correlates of protection in a Latino-origin population
$1,413,439Carlos A Sariol · University Of Puerto Rico Med Sciences · U01 · FY2020 · CA
Pandemic influenza DNA vaccine Development
$1,413,407Lawrence R Smith · Vical, Inc. · U01 · FY2007 · AI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis
$1,413,190Jerrold J. Ellner · Boston Medical Center · U19 · FY2018 · AI
Experimental Animal Models of TB: Chemotherapeutics and Imaging
$1,413,031Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Immunosuppression-free transplantation through placental mimicry
$1,413,000Jessica Diane Weaver · Arizona State University-Tempe Campus · DP2 · FY2021 · AI
Component: Husbandry and Management Core
$1,412,907Kamm Prongay · Oregon Health & Science University · U42 · FY2022 · OD
Component: Husbandry and Management Core
$1,412,907Kamm Prongay · Oregon Health & Science University · U42 · FY2020 · OD
Component: Husbandry and Management Core
$1,412,907Kamm Prongay · Oregon Health & Science University · U42 · FY2021 · OD
Component: Husbandry and Management Core
$1,412,906Kamm Prongay · Oregon Health & Science University · U42 · FY2023 · OD
Task C12: Infectivity and Lethality of Filovirus Strains in NHP
$1,412,891University Of Texas Med Br Galveston · N01 · FY2012 · AI
Seasonal Influenza Vaccine Effectiveness in a Tropical Developing African Country
$1,412,877John Christian Victor · Path · U01 · FY2009 · IP
Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic Vaccination
$1,412,696Dan H. Barouch · Beth Israel Deaconess Medical Center · P01 · FY2023 · AI
Poxvirus Biology
$1,412,229Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Recombinant Virus Vaccines
$1,412,229Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI